Login

Join for Free!
118864 members
table of contents table of contents

Biology Articles » Health and Medicine » Medicine and Diagnosis » History of cannabis as a medicine: a review » References

References
- History of cannabis as a medicine: a review

1. Li HL, Lin H. An archaeological and historical account of cannabis in China. Econ Bot. 1974;28(4):437-47.

2. Touwn M. The religious and medicinal uses of Cannabis in China, India and Tibet. J Psychoactive Drugs. 1981;13(1):23-34.

3. Leson G, Pless P. Hemp seed and hemp oil. In: Grotenhermen F, Russo E, eds. Cannabis and cannabinoids. New York: The Haworth Integrative Healing Press; 2002. Chapter 38. p. 411-25.

4. Li HL. Hallucinogenic plants in Chinese herbals. J Psychodelic Drugs. 1978;10(1):17-26.

5. Paris M, Nahas GG. Botany: the unstabilizad species. In: Nahas GG, editor. Marihuana in science and medicine. New York: Raven Press; 1984. p. 3-36.

6. Mikuriya TH. Marijuana in medicine: past, present and future. Calif Med. 1969;110(1):34-40.

7. Aldrich M. History of therapeutic cannabis. In: Mathre ML, eds. Cannabis in medical practice. Jefferson, NC: Mc Farland; 1997. p. 35-55.

8. Fankhauser M. History of cannabis in Western Medicine. In: Grotenhermen F, Russo E, eds. Cannabis and Cannabinoids. New York: The Haworth Integrative Healing Press; 2002. Chapter 4. p. 37-51.

9. Du Toit BM. Cannabis in Africa. Rotterdam: Balkema; 1980.

10. Pinho AR. Social and medical aspects of the use of cannabis in Brazil. In: Rubin V, eds. Cannabis and culture. Paris: Mounton Publishers; 1975. p. 293-302.

11. Brill H, Nahas GG. Cannabis intoxication and mental illness. In: Nahas GG, eds. Marihuana in science and medicine. New York: Raven Press; 1984. p. 263-306.

12. Moreau JJ. Du Hachisch et de l'Alienation Mentale: Etudes Psychologiques. Paris: Librarie de Fortin Mason; 1845 (English edition: New York, Raven Press; 1972).

13. Grinspoon L. Marihuana reconsidered. Cambridge, MA: Harvard University Press; 1971.

14. Grinspoon L, Bakalar JB. Marihuana: the forbidden medicine. New Haven: Yale University Press; 1993. Chapter 1.

15. Musto DF. The marihuana tax act of 1937. Arch Gen Psychiatry. 1972;26(2):101-8.

16. Harris LS. Cannabis: a review of progress. In: Lipton MA, Dimascio A, Killam KF, eds. Psychopharmacology: a generation of progress. New York: Raven Press; 1978. p. 1565-74.

17. Kandel DB. Marihuana users in young adulthood. Arch Gen Psychiatry. 1984;41(2):200-9.

18. Department of Health and Human Services. Substance Abuse & Mental Health Services Administration – SAMHSA [cited 2006 Jan 12]. Available from: URL: http://oas.samsa.gov/MJ.htm.

19. European Monitoring Centre for Drugs and Drugs Addiction (EMCDDA) Annual Report 2004: "The state of the drugs problem in the European Union and Norway". 1-113. Belgium, 2004. [cited 2006 Jan 15]. Available from: URL: http://ar.emcdda.eu.int/pt/home-pt.htm.

20. Gaoni Y, Mechoulam RJ. Isolation structure and partial synthesis of an active constituent of hashish. J Am Chem Soc. 1964;86:1646-7.

21. Mechoulam RJ. Marijuana: chemistry, pharmacology and clinical effects. New York: Academic Press; 1973. p. 2-99.

22. Russo E. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypotheses. 2006;66(2):234-46.

23. Carlini EA. Conversation with Elisaldo Luiz de Araújo Carlini. Addiction. 2005;100(7):897-907.

24. Martin BR, Mechoulam RJ, Razdan RK. Discovery and characterization of endogenous cannabinoids. Life Sci. 1999;65(6-7):573-95.

25. Carlini EA. The good and bad effects of (-) trans-delta-9- tetrahydrocannabinol (D9-THC) on humans. Toxicon. 2004;44(4):461-7.

26. Mechoulam R, Parker LA, Gallily R. Cannabidiol: an overview of some pharmacological aspects. J Clin Pharmacol. 2002;42(11 Suppl):11S-19S.

27. Zuardi AW, Guimarães FS, Guimarães VM, Del Benl EA. Cannabidiol: possible therapeutic application. In: Grotenhermen F, Russo E, eds. Cannabis and cannabinoids: pharmacology, toxicology and therapeutic potential. New York: The Haword Interactive Healing Press; 2002. Chapter 33. p. 359-69.

28. Pope HG Jr, Gruber AJ, Hudson JI, Cohane G, Huestis MA, Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend. 2003;69(3):303-10.

29. Arseneault L, Cannon M, Witton J, Murray RM. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry. 2004;184:110-7.


rating: 5.20 from 10 votes | updated on: 19 Dec 2006 | views: 12892 |

Rate article:







excellent!bad…